BioArctic and Mesenkia enter oncology research collaboration

Contributed by: PR Newswire

Tags

BIOARCTIC-Collab

More Like This

BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology

BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties

BioArctic and Eisai sign research evaluation agreement regarding BAN2802

BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program

The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association

BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

BrainTransporter™ dramatically improves antibody delivery to the brain